Angiotensin-converting-enzyme inhibitor-induced angioedema. [PDF]
Quickfall D, Jakubovic B, Zipursky JS.
europepmc +1 more source
Angiotensin-converting enzyme inhibitor fetopathy. [PDF]
Peter G. Pryde +3 more
openalex +1 more source
Angiotensin-Converting Enzyme Inhibitor (ACEI)-Induced Angioedema After Re-exposure to Lisinopril: A Case Report and Clinical Review. [PDF]
Tou LC, DeMott JD, Palacios JM.
europepmc +1 more source
A Review of the Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of Angiotensin-Converting Enzyme Inhibitors: Focus on Perindopril [PDF]
Arnaud Ancion +4 more
openalex +1 more source
In this review, agents such baicalein, troxerutin, epigallocatechin gallate, quercetin, melatonin, valproic acid, lithium, neurosteroid progesterone, as well as minocycline have been implicated as neuroprotective agents for irradiation‐induced neurological deficits. Also, agents such as glucocorticoids, methylphenidate, vitamin E, bisdemethoxycurcumin,
Seidu A. Richard +2 more
wiley +1 more source
Impact of Angiotensin-Converting Enzyme Inhibitor on Coronary Artery Calcification Evaluated by Intravascular Ultrasound: A Retrospective Cohort Study. [PDF]
Kanda D +8 more
europepmc +1 more source
Angiotensin-Converting Enzyme Inhibitor-Induced Small Bowel Angioedema: An Important Differential for Episodic Enteritis. [PDF]
Mingos N, Tjandra D, Lim B, Hebbard G.
europepmc +1 more source
Therapy Code List - Angiotensin converting enzyme inhibitors/angiotensin receptor blockers
Elizabeth Crellin +8 more
openalex +1 more source
Therapeutic role of nifedipine in threatened preterm labor: Current evidence and future perspectives
Abstract Preterm birth occurs in approximately 10% of all pregnancies, and is not only the leading cause of neonatal mortality but also a major contributor to short‐ and long‐term morbidities due to immaturity. Preterm birth has also been linked to an increased risk of maternal cardiovascular and cerebrovascular diseases, making it a critical concern ...
Hikaru Imatake +4 more
wiley +1 more source

